Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218296 · ClinicalTrials.gov registry record · Phase 2
Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 332
- Enrollment target
NCT00218296 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 332 participants.
The verdict
NCT00218296, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 332 participants
- Enrollment target
Study Summary
Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally effective and may motivate individuals to eventually quit using tobacco. This study will compare the effectiveness of a ST reduction treatment program versus a usual tobacco cessation treatment program (immediate cessation) for reducing tobacco use in ST users.
Interventions
- DRUG Usual Care Group
- OTHER Reduction Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218296
The ClinicalTrials.gov registry entry for NCT00218296 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care Group is the first listed.
NCT00218296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218296 about?
NCT00218296 is a clinical study titled "Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use". Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally eff...
What is the current status of trial NCT00218296?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 332 participants. The study started on 2006-11. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00218296?
The interventions under investigation include: Usual Care Group (DRUG), Reduction Group (OTHER).
Who is sponsoring clinical trial NCT00218296?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.